Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
 
 Nuclear receptors
 
 Ion channels
 
 Transporters
 
 Enzymes
 
 Protein kinases
 
 Cytokines
 
 Others
   Cell adhesion molecules (CAMs)
   Cellular antigens
     CD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]
     CD5 [HSA:921] [KO:K06455]
     CD11a [HSA:3683] [KO:K05718]
     CD19 [HSA:930] [KO:K06465]
     CD20 [HSA:931] [KO:K06466]
     CD22 [HSA:933] [KO:K06467]
     FCER2 (CD23) [HSA:2208] [KO:K06468]
     CD33 [HSA:945] [KO:K06473]
     CD49d [HSA:3676] [KO:K06483]
       Firategrast
       Natalizumab
         D06886  Natalizumab (genetical recombination) (JAN)
Monoclonal antibody
     CD51 (integrin alpha V) [HSA:3685] [KO:K06487]
     CD52 [HSA:1043] [KO:K06488]
     CD54 (ICAM-1) [HSA:3383] [KO:K06490]
     NCAM (CD56) [HSA:4684] [KO:K06491]
     CD58 (LFA3) [HSA:965] [KO:K06492]
     CD62E [HSA:6401] [KO:K06494]
     CD62P [HSA:6403] [KO:K06496]
     CD66 (CEACAM) [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
     CD74 [HSA:972] [KO:K06505]
     CD80 [HSA:941] [KO:K05412]
     CD80/86 [HSA:941 942] [KO:K05412 K05413]
     CD152 (CTLA4) [HSA:1493] [KO:K06538]
     killer-cell immunoglobulin-like receptor, two domains [HSA:3802 3803 3804 3805 57292 553128 3806 100132285 3808 3809 3810] [KO:K07981 K07982]
     CD200 [HSA:4345] [KO:K06556]
     CD227 [HSA:4582] [KO:K06568]
     CD279 [HSA:5133] [KO:K06744]
     CD288 [HSA:51311] [KO:K10170]
     CD304 [HSA:8829] [KO:K06724]
     CD319 (CS1) [HSA:57823] [KO:K06733]
     CD326 (EpCAM) [HSA:4072] [KO:K06737]
     CA125 [HSA:94025] [KO:K16145]
     HLA-DR beta [HSA:3123 3125 3126 3127] [KO:K06752]
   Toll-like receptor
   Antibodies
   Complement system
   Nucleic acid
   Translation factor
   Drugs
   Other

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: June 15, 2017

» Japanese version